Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.10.0.1
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 09, 2018
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Entity Registrant Name Cellectar Biosciences, Inc.  
Entity Central Index Key 0001279704  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Trading Symbol CLRB  
Entity Common Stock, Shares Outstanding   4,757,786
Entity Emerging Growth Company false  
Entity Small Business true